Search
for

    Sort by

    Research 361–390 of 1000+

    1. Tofacitinib for the treatment of lichen planopilaris: A case series Dermatologic therapy · 2018 · 79 citations
    2. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers Experimental Dermatology · 2016 · 70 citations
    3. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 · 25 citations
    4. Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata Journal of the American Academy of Dermatology · 2018 · 11 citations
    5. Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata EBioMedicine · 2015 · 11 citations
    6. Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population International Journal of Environmental Research and Public Health · 2022 · 5 citations
    7. Estimation of health utility values for alopecia areata Quality of Life Research · 2024 · 4 citations
    8. A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years. PubMed · 2024 · 2 citations
    9. Alopecia Areata and Alopecia Areata Incognita Elsevier eBooks · 2018 · 1 citations
    10. Registrars and Fellows Update Session 2 Australasian Journal of Dermatology · 2017
    11. Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study Acta Dermato Venereologica · 2026
    12. Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies International Journal of Drug Delivery Technology · 2026
    13. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    14. Pharmacotherapy of alopecia areata Forum Dermatologicum · 2026
    15. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review Journal of Dermatological Treatment · 2025
    16. Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study SKIN The Journal of Cutaneous Medicine · 2025
    17. Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System Military Medicine · 2024
    18. Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe? Frontiers in Immunology · 2024
    19. Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha Open Repository of the University of Porto (University of Porto) · 2024
    20. Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatology and therapy · 2023
    21. A Novel Hope for Alopecia Totalis Patients: Case Report Dubai medical journal · 2020
    22. Alopecia Areata Springer eBooks · 2016
    23. Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway Journal of Molecular Cell Biology · 2023 · 6 citations
    24. Broussonetia papyrifera Promotes Hair Growth Through the Regulation of β-Catenin and STAT6 Target Proteins: A Phototrichogram Analysis of Clinical Samples Cosmetics · 2020 · 4 citations
    25. Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell Evidence-based Complementary and Alternative Medicine · 2015 · 6 citations
    26. European expert consensus statement on the systemic treatment of alopecia areata 2024 · 4 citations
    27. The new era of JAK inhibitors: Impelling updates in Alopecia Areata Guideline Journal of the European Academy of Dermatology and Venereology · 2023 · 1 citations
    28. Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation 2025
    29. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology Clinical & Translational Oncology · 2026
    30. Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata Acta Dermato Venereologica · 2025